GlaxoSmithKline
TOPIC
 / company

GlaxoSmithKline

GlaxoSmithKline
GlaxoSmithKline
The London-based multinational drugmaker, also known as GSK, supplies key products such as vaccines in China, as well as drugs for lung disease and cancer. In 2013, the company was targeted by Chinese authorities over alleged corruption, price-fixing and quality controls.
Chairman / President
Jonathan Symonds
CEO / Managing Director
Dame Emma Natasha Walmsley
CFO / Finance Director
Julie Brown
Industry
Pharmaceutical
Website
gsk.com
Headquarters address
79 New Oxford Street, London, WC1A 1DG, United Kingdom
Stock Code
NYSE:GSK
LSE:GSK
Year founded
2000
A worker checks the position of a feeding tray in a pharmaceutical manufacturing facility at the Hengrui Biomedical Industrial Park in Lianyungang in Jiangsu province, on December 13, 2021. Photo: Getty Images
China economy

Opinion | How China engineered the rapid rise of its drug innovation industry

A market once dominated by generics is now an AI-powered pharmaceutical hub drawing billion-dollar investments from the likes of Pfizer and GSK.

videocam
Hong Kong economy

Letters | How Hong Kong can help Chinese drug makers go global

Hong Kong economy

Digital IP protector from US among 18 firms expanding in Hong Kong under OASES

Hong Kong healthcare and hospitals

Hong Kong to launch collaborative study on long-term effects of shingles vaccine

Study by clinical trial institute, University of Hong Kong and drug giant GlaxoSmithKline will assess potential of heart and dementia protection.

Memorandum of understanding signing ceremony between the University of Hong Kong, GlaxoSmithKline and the Greater Bay Area International Clinical Trial Institute for a study to examine the long-term health effects of the shingles vaccine. Photo: Sun Yeung
Biomedicine: Companies

China’s Jiangsu Hengrui signs licensing deal with Braveheart Bio for heart drug

The licensing deal for the HRS-1893 innovative drug could fetch as much as US$1.01 billion in milestone payments.

Biomedicine: Companies

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Novel drug roll-outs and revenue from licensing buoy results.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

Opinion | Biotech successes helping Chinese intellectual property go global

After years of buying licences for foreign-made medicines, Chinese biotech firms are now profiting handsomely from their own innovations.

videocam
Visitors walk beside the booth of British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca during the third China International Supply Chain Expo in Beijing on July 17. Photo: EPA
Biomedicine: Companies

GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects

The deal would give GSK the rights to develop the drug for HRS-9821 and 11 preclinical programmes owned by Jiangsu Hengrui Pharmaceuticals.

4
Indonesia

Is Indonesia a ‘guinea pig’ in Bill Gates-backed TB vaccine trial?

The controversy began after President Prabowo Subianto said that Bill Gates was developing a tuberculosis vaccine to be tested in Indonesia.

8
United States

FDA approves GSK vaccine to combat meningococcal infections

Meningococcal infections can lead to severe, sometimes deadly, bloodstream infections, and severe swelling in the brain and spinal cord.

The GSK (GlaxoSmithKline) logo is seen in this illustration. Photo: Reuters
Medicine

WHO recommends malaria vaccine for children, to be rolled out next year

The vaccine, developed in the UK, will become available to countries by mid-2024 and doses will cost between US$2 and US$4, said WHO chief Tedros Adhanom Ghebreyesus on Monday.

videocam
A nurse fills a syringe with malaria vaccine at the Lumumba Sub-County hospital in Kisumu, Kenya. Photo: Reuters
Coronavirus pandemic

This man says he can beat Covid-19 with nasal sprays, not needles

Marty Moore, founder of Meissa Vaccines, says nasal sprays could be the future of the fight against Covid-19 and its variants by building better protection where the battle begins.

Coronavirus pandemic

GlaxoSmithKline to manufacture Novavax Covid-19 vaccine in UK

The agreement has the potential to reduce the UK’s reliance on overseas vaccine supplies amid a spat with the EU over exports.

Health & Fitness

Chinese drugs firm aims to bring down cost of breast cancer treatment

Shanghai-based Genor Biopharma plans to seek regulatory approval for coprelotamab to be used in China on late-stage breast cancer patients.

videocam
Breast cancer accounted for nearly 20 per cent of all female cancer incidences in China in 2018, according to the World Health Organization. Photo: View Portfolio
Medicine

In pandemic lesson, drug maker Stada turns to China for supply security

Stada Arzneimittel, owned by private equity firms Bain Capital and Cinven, is turning to China to enhance its supply security and boost sales presence in Asia’s biggest pharmaceutical market.

videocam
An employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpa
Britain

UK watchdog investigates Chinese broadcaster for airing ‘forced confession’

Briton Peter Humphrey and his wife, Yu Yingzeng, were sentenced in China in 2014 for illegally obtaining and selling private records of Chinese citizens.

Disease

Malawi becomes world’s first country to roll out malaria vaccine

After more than three decades in development and almost US$1 billion in investment, the new vaccine began to be distributed in Lilongwe, the nation’s capital.

Advertisement
Advertisement
Advertisement
Corruption in China

China, US and hard cash are emboldening corporate whistle-blowers

videocam
China offers many opportunities for corporate whistle-blowers who want to obtain a reward for reporting violations of America’s Foreign Corrupt Practices Act to the US Securities and Exchange Commission. Photo: Bloomberg
Medicine

U.S. FDA approves GSK next-generation HIV drug dolutegravir

Wellness

Alibaba partners with GSK for online HPV vaccine service

Corruption in China

US judge dismisses lawsuit against GSK over China whistle-blower

A judge in the United States has dismissed a lawsuit by two former corporate investigators who accused British pharmaceutical company GlaxoSmithKline of misleading them into investigating a whistle-blower in China. Photo: Xinhua
Corruption in China

How Western firms in China can avoid the corruption dragnet

Shelves of milk powder at a supermarket in Beijing in July 2013, amid an investigation into alleged price-fixing by foreign firms in the infant formula sector. Photo: AFP
Business Insider

New joint venture to study electronic implants for conditions like diabetes and asthma

Nowhere to hide from bribery laws

At a closed-door trial held last month in Hunan province, one-time high-flying business executive Mark Reilly was handed a three-year suspended prison sentence for his role in the largest corporate bribery scandal involving a foreign firm in China.

Hong Kong hot spot for lawyers

When Cathy Palmer first came to Hong Kong as a US prosecutor more than 20 years ago, she was chasing heroin-smuggling triads who later sent a booby-trapped package to her Brooklyn office.

GlaxoSmithKline was fined a record US$489 million in China last month for bribing doctors to help sales of its drugs. Photo: Reuters

Multinationals in China on alert in wake of GSK case

In the wake of the Chinese government's punishment of GSK and some of its former senior executives for corruption, multinationals are changing their behaviour and strategies in China, said industry observers.

The central government's corruption probe into GSK prompted other multinationals to increase their attention on compliance. Photo: AP
Alibaba

Mr. Shangkong | The tale of Alibaba and GSK a sign of China's rise on world stage

Alibaba celebrated its landmark US$21.8 billion listing in New York on Friday - the largest IPO in American history - on the same day that GlaxoSmithKline was hit by a record fine of US$500 million imposed by the central government.

GlaxoSmithKline hit with record 3b yuan fine for bribing Chinese doctors

China has imposed a record fine of three billion yuan (HK$3.78 billion) on British pharmaceuticals giant GlaxoSmithKline (GSK) for bribing doctors to use its drugs.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement